Association between serum β2-microglobulin levels and the risk of all-cause and cardiovascular disease mortality in chinese patients undergoing maintenance hemodialysis
暂无分享,去创建一个
Zhihong Wang | Shuang Zhang | Cui Dong | Jia Xiao | Lian-Lian You | Yu-Xin Jin | Shuxia Liu | Ting-Ting Kuai | Yu Zhang
[1] B. Urquhart,et al. Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets , 2021, Toxins.
[2] J. Perl,et al. Beta-2 microglobulin and all-cause mortality in the era of high-flux hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study , 2020, Clinical kidney journal.
[3] Rachael C. Walker,et al. Supportive care for end-stage kidney disease: an integral part of kidney services across a range of income settings around the world. , 2020, Kidney international supplements.
[4] A. Cheung,et al. Markers of kidney tubule function and risk of cardiovascular disease events and mortality in the SPRINT trial. , 2019, European heart journal.
[5] S. Lekawanvijit. Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome , 2018, Toxins.
[6] H. Fujii,et al. Role of Uremic Toxins for Kidney, Cardiovascular, and Bone Dysfunction , 2018, Toxins.
[7] R. Vasan,et al. Serum β-Trace Protein and β2-Microglobulin as Predictors of ESRD, Mortality, and Cardiovascular Disease in Adults With CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study. , 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[8] M. Chonchol,et al. Recent advances in the management of hemodialysis patients: a focus on cardiovascular disease , 2014, F1000prime reports.
[9] K. Andrassy,et al. Comments on 'KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease'. , 2013, Kidney international.
[10] B. Stecher,et al. The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease. , 2013, Kidney international.
[11] Xuemei Li,et al. Mortality rates among prevalent hemodialysis patients in Beijing: a comparison with USRDS data. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[12] H. Kim,et al. Higher serum beta2-microglobulin levels are associated with better survival in chronic hemodialysis patients: a reverse epidemiology. , 2011, Clinical Nephrology.
[13] À. Argilés,et al. Levels of circulating endothelial progenitor cells are related to uremic toxins and vascular injury in hemodialysis patients , 2009, Journal of thrombosis and haemostasis : JTH.
[14] M. Inaba,et al. Serum beta2-microglobulin level is a significant predictor of mortality in maintenance haemodialysis patients. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[15] J. Jankowski,et al. A bench to bedside view of uremic toxins. , 2008, Journal of the American Society of Nephrology : JASN.
[16] K. Farrington,et al. Relative Importance of Residual Renal Function and Convection in Determining Beta-2-Microglobulin Levels in High-Flux Haemodialysis and On-Line Haemodiafiltration , 2007, Blood Purification.
[17] M. Haberal,et al. Cardiac troponin I and beta 2 microglobulin as risk factors for early‐onset atherosclerosis in patients on haemodialysis , 2005, Nephrology.
[18] D. Fliser,et al. Uremia causes endothelial progenitor cell deficiency. , 2004, Kidney international.
[19] Bertram L Kasiske,et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Circulation.
[20] Bertram L Kasiske,et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Hypertension.
[21] Q. Yi,et al. Beta2-microglobulin as a potential initiator of inflammatory responses. , 2003, Trends in immunology.
[22] Peter Stenvinkel,et al. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. , 2002, Kidney international.
[23] N. Chen,et al. Signal transduction of beta2m-induced expression of VCAM-1 and COX-2 in synovial fibroblasts. , 2002, Kidney international.
[24] A. Levey,et al. Cardiovascular disease and chronic renal disease: a new paradigm. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[25] J. Daugirdas. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. , 1993, Journal of the American Society of Nephrology : JASN.
[26] K. Mazanec,et al. [Beta 2-microglobulin amyloidosis]. , 1992, Ceskoslovenska patologie.
[27] J. Floege,et al. Clearance and synthesis rates of beta 2-microglobulin in patients undergoing hemodialysis and in normal subjects. , 1991, The Journal of laboratory and clinical medicine.
[28] G. Eknoyan,et al. Association between serum 2-microglobulin level and infectious mortality in hemodialysis patients. , 2008, Clinical journal of the American Society of Nephrology : CJASN.
[29] E. Fung,et al. Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies. , 2007, Circulation.
[30] William Clark,et al. Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. , 2006, Journal of the American Society of Nephrology : JASN.
[31] G. Lonnemann,et al. Beta(2)-microglobulin amyloidosis: effects of ultrapure dialysate and type of dialyzer membrane. , 2002, Journal of the American Society of Nephrology : JASN.
[32] H. Mano,et al. Beta(2)-microglobulin identified as an apoptosis-inducing factor and its characterization. , 1999, Blood.
[33] E. Appella,et al. Beta 2-microglobulin. , 1984, Methods in enzymology.
[34] A Vyskocil,et al. Determination of beta 2-microglobulin in human urine and serum by latex immunoassay. , 1981, Clinical chemistry.
[35] J. Revillard,et al. Beta-2-microglobulin and HLA-related glycoproteins in human urine and serum. , 1981, Contributions to nephrology.